{
    "2019-03-28": [
        [
            {
                "time": "2019-03-28",
                "original_text": "New York sues billionaire family behind maker of OxyContin",
                "features": {
                    "keywords": [
                        "lawsuit",
                        "billionaire",
                        "OxyContin"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-03-28",
                "original_text": "AstraZeneca's Forxiga Gets Nod in Japan for Type I Diabetes",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Forxiga",
                        "approval"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-03-28",
                "original_text": "More Mud on Johnson & Johnson?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "controversy"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-03-28",
                "original_text": "The Zacks Analyst Blog Highlights: Roche, Celgene, Johnson and Johnson, Bayer and Sunesis Pharmaceuticals",
                "features": {
                    "keywords": [
                        "Zacks",
                        "analyst",
                        "Roche",
                        "Celgene",
                        "Johnson and Johnson",
                        "Bayer",
                        "Sunesis Pharmaceuticals"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-28",
                "original_text": "Johnson & Johnson Vision Announces Availability of ACUVUE OASYS with TRANSITIONS LIGHT INTELLIGENT TECHNOLOGY in Canada",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "ACUVUE",
                        "availability",
                        "Canada"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-28",
                "original_text": "State's opioid suit hits billionaire family behind OxyContin",
                "features": {
                    "keywords": [
                        "opioid",
                        "lawsuit",
                        "billionaire",
                        "OxyContin"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-03-28",
                "original_text": "This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "dividend",
                        "stock"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-28",
                "original_text": "NY opioid lawsuit hits billionaire family behind OxyContin",
                "features": {
                    "keywords": [
                        "lawsuit",
                        "opioid",
                        "billionaire",
                        "OxyContin"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-03-28",
                "original_text": "3 Small Biotech Stocks Hitting New Highs",
                "features": {
                    "keywords": [
                        "biotech",
                        "stocks",
                        "new highs"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-28",
                "original_text": "Health Care Sector Update for 03/28/2019: CTST, AMRN, VLRX, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "healthcare",
                        "sector",
                        "update",
                        "CTST",
                        "AMRN",
                        "VLRX",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-28",
                "original_text": "Johnson & Johnson prevails in New Jersey talc cancer trial",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "talc",
                        "cancer",
                        "trial"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-28",
                "original_text": "PRESS DIGEST- New York Times business news - March 28",
                "features": {
                    "keywords": [
                        "press digest",
                        "business news",
                        "New York Times"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-03-28",
                "original_text": "J&J's Sudden Talc-Cancer Settlements Aren't Its Usual Style",
                "features": {
                    "keywords": [
                        "J&J",
                        "talc-cancer",
                        "settlements"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-03-28",
                "original_text": "New York sues Purdue Pharma and Sackler family over opioid crisis",
                "features": {
                    "keywords": [
                        "lawsuit",
                        "Purdue Pharma",
                        "Sackler",
                        "opioid"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-03-28",
                "original_text": "New Jersey jury finds J&J not liable in talc cancer trial; company settles 3 other cases",
                "features": {
                    "keywords": [
                        "J&J",
                        "talc",
                        "cancer",
                        "trial",
                        "settlement"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-28",
                "original_text": "New Jersey jury finds J&J not liable in talc cancer trial; company settles three other cases",
                "features": {
                    "keywords": [
                        "J&J",
                        "talc",
                        "cancer",
                        "trial",
                        "settlement"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}